Scottsdale, AZ - (NewMediaWire) - February 27, 2019 - CBD Life Sciences Inc. (OTC: OCSYD) is pleased to announce that its wholly owned subsidiary, LBC Bioscience Inc., completely sold out of all its products at the recently held Fountain Hills Great Fair, generating over $10,000 in sales in two days. Now in its 32nd year, the annual Fountain Hills Great Fair features over 500 select artisans from around the world offering unique products and one-of-a kind works. LBC Bioscience was 1 of 5 CBD exhibitors at the event.“We were very pleased with the response from this show,” stated Lisa Nelson, President of CBD Life Sciences. “To sell out our entire inventory in two days not only reflects on the growing acceptance of CBD but also speaks highly of the quality of our products. This is the first of many shows we have planned along with an aggressive online marketing and print advertising campaign. Our goal is to generate over $1 million in sales this year,” continued Ms. Nelson.About CBD Life Sciences Inc.CBD Life Sciences Inc. is a publicly traded company, having its common shares quoted on the OTC Markets under the symbol ‘OCSYD’. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector.About LBC Bioscience Inc. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions, supplements, edibles, and a full line of pet products. In addition, LBC is in the process of developing an anti-aging skin product line. LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com.Forward-Looking StatementsExcept for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Optium Cyber Systems, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.Safe Harbor StatementThis release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.Contact Information Investor Relations Ten Associates LLC 11529 N. 120th St. Scottsdale, Arizona 85259 USA Telephone: 480-326-8577 Contact: Thomas E. Nelson Email: tenassociates33@gmail.com

Brookfield, WI - (NewMediaWire) - February 27, 2019 - Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, Brain Armor® and NorthShore University HealthSystem (NorthShore) have successfully begun laboratory experimentation utilizing Trident Brands’ proprietary formulas for study of their effects on mitigation of the effects of traumatic brain injury. While both severe and mild traumatic brain injury (concussion) have been a major problem for the general population, athletes, and active duty military personnel, no pharmacological treatment has emerged to reduce brain injury or facilitate the brain’s healing process. The cornerstone of the therapy involves the brain’s primary fatty acid, docosahexaenoic acid or DHA, which has previously been shown to have beneficial effects in such injuries, but investigators are also researching the potential for cannabinoids to limit injury or improve upon the healing process. Results are expected to be announced later this year. "We are enthusiastic about this collaboration and continuing our laboratory's experimental work on brain injury, cellular mechanisms, and protection,” said Julian Bailes, MD, Chairman of the Department of Neurosurgery at NorthShore and co-director of the NorthShore Neurological Institute. “The potential for improvement in the brain's responses to inflammation, compromise in blood flow, traumatic damage, and repetitive impacts are areas of exciting research. This ongoing work should open up areas of additional understanding and insight for better outcomes from mild traumatic brain injury." “This initial research collaboration with NorthShore will establish a firm foundation for our future research which will focus on determining the potential for prevention of injury and further determining ability to repair after injury. Through this research, Brain Armor will be able to create new, scientifically validated nutritional and supplement programs designed specifically for optimal brain health and improved cognitive performance. We are thrilled to partner with NorthShore in challenging the status quo of current brain-related knowledge,” says Alan Jones, Chief Development Officer for Trident Brands, Inc. About NorthShore University HealthSystem NorthShore University HealthSystem (NorthShore) is an integrated healthcare delivery system consistently ranked as a Top 15 Major Teaching Hospital in the U.S. The NorthShore system, headquartered in Evanston, Illinois, includes four hospitals – Evanston, Glenbrook, Highland Park and Skokie. NorthShore also includes a 950+ physician multispecialty group practice, NorthShore Medical Group, with more than 140 practices in the Chicagoland area. NorthShore is a Magnet recognized organization, the first in Illinois to receive this prestigious honor as an entire system that demonstrates nursing excellence and high standards in patient care. The system also includes the NorthShore Research Institute; the NorthShore Foundation; and the NorthShore Home & Hospice Services. As a not-for-profit organization, NorthShore provides $235 million in charitable care and services to the communities it serves, while philanthropic support from individuals and organizations enhances clinical care, research and education programs across the system. For more information, please visit www.northshore.org. About Brain Armor® Brain Armor is on a mission to improve cognitive health, well-being and performance at every stage of life and on every field of play. Our products are clinically-proven dietary supplements formulated with healthy fats and vital nutrients, designed to support structural brain health and performance. Brain Armor products are vegetarian, made in the USA and are a regular part of many professional and elite amateur athlete and team conditioning programs. Brain Armor Inc. is a subsidiary of Trident Brands Incorporated (OTCQB: TDNT -- tridentbrands.com). For more information, please view www.brain-armor.com. About Trident Brands, Inc. Trident Brands Incorporated is a publicly-traded nutraceutical company ...

Fort Lauderdale, FL - (NewMediaWire) - February 27, 2019 - Veritas Farms, Inc. (the “Company”) (OTCQB: VFRM), a vertically integrated agribusiness focused on the production of full spectrum hemp extracts with naturally occurring cannabinoids, has entered into an exclusive formulation and manufacturing agreement with PurWell, LLC (“PurWell”), an affiliate of VirtuOx, Inc. (“VirtuOx”), the nation’s largest home respiratory and sleep diagnostics provider with over 30,000 new patients each month.Under the Agreement, Veritas Farms will manufacture a custom formulated line of hemp extract products for PurWell to be sold under the PūrWell brand. The products will include PūrSlēp, a full spectrum hemp oil combined with a proprietary blend of holistic natural supplements widely known to promote effective sleep.Alexander M. Salgado, CEO and co-founder of Veritas Farms, Inc., commented, “As an affiliate of the nation’s largest home respiratory and sleep diagnostics provider, we are excited to work with PurWell as exclusive formulation and manufacturing partner for PūrSlēp and the PūrWell brand that was recently launched online and at select healthcare providers across the country. We look forward to providing them a consistent and dependable supply of our best-in-class full spectrum hemp oil products and being an important part of their long-term success.”Formulated and manufactured at the Veritas Farms grow, processing, and production facilities in Pueblo, Colorado, without the use of any pesticides, herbicides, or fungicides, each batch of PūrSlēp and the entire PūrWell line of products will be laboratory tested for purity and potency. PūrSlēp’s formulation includes full spectrum hemp oil, GABA, hops flower extract, valerian root, chamomile flower extract, l-tryptophan, melatonin, MCT oil, and organic essential oil. PūrSlēp is vegan, sugar-free, gluten free, and alcohol-free, and it contains no artificial colors or flavors. PūrSlēp is available online now at www.purwell.com and at select physician’s offices, pharmacies, and medical equipment retailer locations. About VirtuOx, Inc. and PurWell, LLCVirtuOx, Inc. (www.virtuox.net) is the nation’s largest home respiratory and sleep diagnostics provider, testing 30,000+ new patients each month for conditions such as sleep apnea, insomnia, and cardiac arrythmias. VirtuOx Inc. has received full accreditation by The Joint Commission as an Ambulatory Care Sleep Diagnostic Center.PūrWell, LLC. (www.purwell.com) is dedicated to making high quality, reliable Full Spectrum Hemp Oil products for the healthcare marketplace. PūrWell offers physicians and other healthcare professionals the ability to sell Full Spectrum Hemp Oil products through the industry’s only zero cost-of-entry sales model. For more information, send inquiries to info@purwell.com. About Veritas Farms, Inc.Veritas Farms, Inc. (OTCQB: VFRM) is a vertically integrated agribusiness focused on producing superior quality, whole plant, full spectrum hemp oils and extracts containing naturally occurring cannabinoids. The Company currently operates a 140-acre farm and production facilities in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp. The Company markets and sells products under its Veritas Farms™ brand and manufactures private label products for a number of leading distributors and retailers. Veritas Farms™ brand full spectrum hemp extract products include vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, and oral syringes in a variety of size formats and flavors. All Veritas Farms™ brand products are third-party laboratory tested for strength and purity. The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.For additional information and online product purchase, visit www.theveritasfarms.com. Cautionary Language Concerning Forward-Looking StatementsThis press release contains “forward-looking statements” within the meaning of the safe ...

Barcelona, SPAIN - (NewMediaWire) - February 27, 2019 - At the MWC 2019, Huawei released four latest use cases for wireless fiber: wireless to the home (WTTh), wireless to the enterprise (WTTe), wireless to the building (WTTb), and wireless to the camera (WTTc). These use cases will popularize broadband access and drive forward the development of digital society in the future.Rapid advances in radio technologies over the past few decades have led to the development of wireless fiber. As a result, wireless fiber now offers network capacity and a peak UE rate of more than 1 Gbit/s. Wireless fiber has many benefits, such as rapid deployment, fiber-like experience, full-service capability, on-demand, flexible rate improvement, and sustainable 5G-oriented evolution.WTTh4G LTE radio technologies are used to provide home broadband (HBB) services. As LTE evolves, wireless fiber can be used to provide broadband access with high capacity and guaranteed user-perceived throughput. This significantly reduces the cost per GB and creates many opportunities for operators to offer HBB triple play services (data, voice, and video services).An increasing number of mobile operators are using wireless fiber to launch new fixed mobile convergence (FMC) services, bind individual and family packages, improve user loyalty, and, in so doing, quickly increase revenue.WTTeWireless fiber technologies, such as large spectrum, massive MIMO, and high-performance outdoor customer premises equipment (CPE), provide stable broadband access at guaranteed rates, meeting the broadband service requirements of both small- and medium-sized enterprises (SMEs) and branches of larger corporations, for example, mobile offices, virtual private networks, and link redundancy backups.Operators can deploy the ODU+X solution (connecting enterprise devices (X), such as routers, to ODUs) to offer stable fiber-like experience and flexible, scalable enterprise services for SMEs. WTTbBroadband boosts economic growth and the development of digital society. How to boost developing countries' broadband penetration rate and improve digital connections in these countries to meet ordinary families' demand for affordable broadband services is an important consideration for operators.Wireless fiber allows operators to provide affordable broadband access services for ordinary families and aggregate building traffic to a switch or a router connected to the ODU of an outdoor CPE (ODU+X). Multiple households can share one CPE broadband package to lower the broadband access cost per household.Mobile operators can collaborate with local Internet service providers (ISPs) to quickly develop WTTb services, for example, wholesaling high-rate, high-traffic packages to ISPs. ISPs can leverage wireless fiber's flexibility to attract more building users and sell throughput and traffic to end users.WTTcSome operators in Europe and Asia Pacific are considering implementing radio technologies in areas where wired access is difficult to deploy and satellite access is expensive, such as remote mines, oil fields, marine fishery sites, and temporary construction sites. This helps them deploy remote cameras for video backhaul to meet service requirements in specific scenarios. In particular, WTTc, which can be deployed using outdoor CPEs, features superior coverage and can be used for image and video backhaul.As of the second half of 2018, more than 230 operators in over 120 countries were offering WTTx services to 75 million users around the world. Wireless fiber is a 4.5G- or 5G-based enhanced WTTx solution that leverages large bandwidth (over 40 MHz), massive MIMO multiple-antenna technology, and high-performance CPEs to provide fiber-like experience. Wireless fiber has been deployed by more than 10 operators around the world.John Leung John.leung@wmglobal.com

Los Angeles, CA - (NewMediaWire) - February 27, 2019 - Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com, a fully integrated, active cannabis real estate investor and brand licensor for the cannabis sector in the United States and Canada, today announced that Company’s CEO, Suneil Singh Mundie “Neil Mundie”, is now featured in his first CEO webcast Interview on behalf of Agritek Holdings with Uptick Newswire. Mr. Mundie joined host Everett Jolly to discuss the Company’s cultivation, manufacturing, and edibles operations in Colorado, Puerto Rico and California.The interview may be heard by pasting the link below in your browser or clicking here:https://upticknewswire.com/featured-interview-ceo-neil-mundie-of-agritek-holdings-inc-otc-agtk/ The Company will also be featured on Uptick’s (www.Upticknewswire.com) YouTube channel, Twitter, and Stock Day Podcast. “I will continue to tell the Agritek Holding’s story to multiple media and news outlets to ensure the small cap investment audience is fully aware of our continued growth with projects in multiple jurisdictions within the cannabis sector. Our recent licensee approvals and expansion into the edibles and now beverage markets both as THC and CBD offerings in licensed states continues to make us the Company to watch,” stated Mr. Mundie, CEO of Agritek HoldingsThe Agritek Holdings move back into the edibles and cannabis beverage business coincides with the cannabis beverage industry beginning to gain major attention from some of the largest known Companies after Tilray announced the acquisition of Manitoba Oil of Canada and “eyeing the growing CBD food and drink market in the U.S.” Recent news has also expressed that Starbucks could be the first big chain to launch a cannabis based drink. “While some big players are only now starting to get interested in producing a CBD or THC infused drink, AGTK was the first to recognize the infused beverage industry, import and license Hemp beverages to dispensaries several years ago under its symbol MediSwipe, with the launch of Chillo, a hemp based energy drink and C Swiss Tea sold in California, Michigan, and available through Amazon, the largest online retailer in the world.“Agritek still retains all of our contacts, distribution channels and accounts to take advantage of the new explosion of the infused beverage industry and opportunities, and our new beverage product lines debuting next quarter, in my opinion, will surpass anything presently in the marketplace with our custom brands and formulations,” added Mundie.ArcView Market Research in partnership with BDS Analytics, stated that cannabis edibles spending reached $1.4 billion by 2018 and sales are on track to bring in more than $4.1 billion by 2022. But that number could prove to be just a fraction of its potential now that major consumer packaged goods companies are entering the industry. Agritek Holdings currently has three edibles brands and plans for two beverages moving into the US markets.About Agritek Holdings, Inc.Agritek Holdings, Inc. (www.AgritekHoldings.com), is a fully integrated, active investor and operator in the legal cannabis sector. Specifically, Agritek Holdings provides strategic capital and functional expertise to accelerate the commercialization of its diversified portfolio of cannabis related holdings. Currently, the Company is focused on three high-value segments of the cannabis market, including real estate investment, intellectual property/brands, and infrastructure, with operations in three U.S. States, Canada and Puerto Rico. Agritek Holdings, Inc. presently owns or manages property in Colorado, Washington State, Puerto Rico and Canada and has licenses with permitted facilities in California approved for cultivation as well as manufacturing capabilities. The company owns several Hemp and cannabis brands for distribution including "Hemp Pops", Hemp oil wellness products and "California Premiums". Agritek Holdings, Inc. does not directly grow, harvest, or distribute or sell cannabis or any substances that violate or contravene United ...

CHICAGO, IL - (NewMediaWire) - February 27, 2019 - CannaTrac® (“CannaTrac”), the leading cashless mobile payment system solution for the cannabis industry, today announced that the company has released their global application programming interface (“API”) for platforms to easily integrate with CannaCard®.By providing a global API, CannaTrac® greatly simplifies the integration process for programmers. This ease of integration makes adopting the CannaCard® significantly more appealing to a large range of retailers and Point-of-Sale (“POS”) companies looking for a cashless payment solution. Additionally, CannaCard’s integration capabilities include POS systems embedded into seed-to-sale cannabis software programs.“When developing CannaCard®, we knew the importance of developing the software with a global API to make it as easy as possible for retailers and POS companies to adopt our cashless payment solution,” said Tom Gavin, CEO of CannaTrac®. “Our global API just puts us one step closer to serving as the cannabis industry’s go-to cashless payment solution.” CannaTrac’s global API allows programmers to save an immense amount of time and therefore is more cost-effective for companies looking to add CannaCard® as a payment option. CannaTrac® provides all steps for integration besides the direct tie of CannaCard® into the individual retailer’s platform.The CannaCard® presents users with preference options of both a physical card and a free mobile app that allow users to easily upload funds through the app with their checking account, debit card, credit card, and/or cash in person at partnered dispensaries or retail locations. After announcing last month, CannaTrac® had entered into an agreement with 18,000 retail locations predominantly made up of non-cannabis retail locations, the company gained the opportunity to serve consumers as the one-stop card necessary for all transactions.The CannaCard® app can be downloaded for free from Google Play and Apple Store. Consumers can reload their CannaCard® at participating dispensaries and retail stores, or directly through their online/mobile account. The flat fee to load their account is $0.95. ABOUT CANNATRAC®CannaTrac® offers a cashless payment solution for the cannabis industry. With the CannaCard® or our CannaCard App™, both consumers and retailers benefit from the ease and safety of cashless payments.Daniella Ruiz 619-788-1556 daniella@cmwmedia.com

New York, NY - (NewMediaWire) - February 27, 2019 - Alt 5 Sigma, the only cryptocurrency trading platform designed specifically for financial services providers and built with the highest security, accessibility, compliancy and transparency of the industry, is pleased to announce that it has acquired an ownership stake in Wynston Hill Capital LLC, a New York City based FINRA broker dealer.According to the acquisition agreement, Alt 5 Sigma has acquired an ownership stake of Wynston Hill Capital with an option to increase its ownership.“The ownership and partnership with Wynston Hill Capital are very strategic in our development and their dynamic offering truly completes our own products and services offering,” said André Beauchesne, President and CEO of Alt 5 Sigma Inc. “The digital asset industry is very dynamic but requires stringent security, compliancy, and transparency and this partnership positions our firm at the forefront.”“We have been approached by many crypto related companies in the last several years, but Alt 5 Sigma’s management knowledge of the industry, its trading platform, custodian and cold storage services are what the industry desperately need, and we are pleased to be partnering with them,” said Craig Sherman, Chief Executive Officer of Wynston Hill Capital LLC.About Wynston Hill Capital LLCWynston Hill Capital LLC is a full-service boutique investment bank that works with established companies across a diverse universe of industries. The company distinguishes itself by adding value to our individual clients by comprehending and focusing on the short and long-term financial and strategic goals of our clients. We strive on our relationship-based approach- utilising our diverse network of contacts as an opportunity to develop long-lasting partnerships for both clients and partners.About Alt 5 SigmaAlt 5 Sigma is a Fintech specializing in the development and deployment of digital assets trading and exchange platforms. Alt 5 Sigma was created by financial industry specialists out of the necessity to provide the digital asset economy with security, accessibility, compliancy and transparency.Alt 5 Sigma provides its clients the ability to buy, sell and hold digital assets such as Bitcoin, Ethereum, Litecoin, Bitcoin SV, Monero and Ripple, in a safe and secure environment deployed with the best practices of the financial industry. Alt 5 Sigma’s products and services are available to banks, broker dealers, funds, family offices, professional traders, retail traders, digital asset exchanges, digital asset brokers, blockchain developers, and financial information providers.Alt 5 Sigma digital asset custodian services are secured by GardaWorld. GardaWorld is the world's largest privately-owned business solutions and security services company, offering cash management services, physical and specialized security solutions and, with the Crisis24 portal, the dissemination of vetted information related to international security. A partner of choice for private companies, governments, humanitarian organizations, and multinationals with personnel all over the world, GardaWorld employs more than 72,000 highly skilled, dedicated professionals who serve a diverse clientele in North America, Africa, Asia and the Middle East. In the complex world we live in, our reputation is based on the quality of our services, as well as the commitment and integrity of our people.For more information, visit www.alt5sigma.comContact:Alt 5 Sigma: Tel. 1-800-204-6203media@alt5sigma.comWynston Hill Capital LLC: 1-828-767-1015sherman@wynstonhillcapital.comwww.wynstonhillcapital.com

DENVER, CO - (NewMediaWire) - February 27, 2019 - Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Michael Gobel has joined as the company’s Board of Directors to help the company navigate the next steps for larger capital investment and compliance for a planned uplisting to NASDAQ.“Financial management and a strong capitalized organization both play large roles in the progression of our international expansion,” said Phoenix Life Sciences International CEO Martin Tindall. “Michael Gobel’s extensive experience in risk assessment, financial guidance and balancing various capital opportunities will be imperative in implementing a successful long-term financial strategy.” Gobel holds a Master’s degree in Applied Finance from Macquarie University in Sydney and has more than three decades of experience in the finance industry. He serves as Company Director and Portfolio Manager, managing investments and associated risk in local and overseas equity markets. Additionally, Gobel currently serves as a consultant on economic developments and major projects while also representing a variety of interests to federal ministers and senior government advisors. Michael is on a number of Boards including as Deputy Chairman of an Australian Bank, assisting in guiding the company’s corporate governance and strategy, ensuring best practices and encouraging a culture of proactive risk management.“Assessing and choosing financial decisions and managing reducing risk factors will help ensure that Phoenix Life achieves forward progression in company milestones and continual success,” said Phoenix Life’s new Board Member, Michael Gobel. “I look forward to working with a company that has many innovative and potentially revolutionary goals.” To learn more about Phoenix Life Sciences International, please visit http://www.phoenixlife.co.About Phoenix Life Sciences International LimitedPhoenix Life Sciences International Limited is an adaptive healthcare solutions company. Our business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. We strive to create partnerships and integrate these programs for human health into communities worldwide as part of our Global Health Initiative.FORWARD-LOOKING STATEMENTS Information contained in this press release regarding Phoenix Life Sciences International, Limited and its subsidiaries, (the “Companies”) may constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words “plan”, “forecast”, “anticipates”, “estimate”, “project”, “intend”, “expect”, “should”, “believe,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to the Companies herein are expressly qualified in their entirety by the above-mentioned cautionary statement. The Companies disclaim any obligation to update forward-looking statements contained in this press release, except as may be required by law.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the FDA and therefore the products sold by Phoenix Life Sciences International are not available in the U.S.LEGAL DISCLOSUREPhoenix Life Sciences International does not sell or distribute any products in the United States that are in violation of the United States ...

Seattle, WA - (NewMediaWire) - February 27, 2019 - CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Helix TCS Inc. (OTCQB: HLIX), and its recent partnership with the State of Illinois.Helix TCS Inc. (OTCQB: HLIX), through its subsidiary BioTrackTHC, recently teamed up with the State of Illinois to measure the impact of medical cannabis on opioid use in its Opioid Alternative Pilot Program. The program could become a model for other states facing the same problems, while opening the door for more revenue opportunities for Helix TCS’ unique software solutions.The opioid epidemic has become a major health risk for the United States and Canada. After years of overprescribing, opioid addiction affects a record number of individuals that are increasingly turning to dangerous synthetic opioids. These trends have led to a growing number of overdose deaths across North America. The good news is that medical cannabis has helped turn the tide in a growing number of states.Click here to receive an investor deck and corporate updatesGrowing Opioid EpidemicDrug overdoses have become the leading cause of death of Americans under 50—and two-thirds of those deaths come from opioids. As the most prescribed class of drugs in the U.S., long-term opioid use has skyrocketed over the past several years. Painkiller prescriptions tripled from 76 million to 219 million per year between 1991 and 2011, and nowadays, nearly 300 million prescriptions are issued each year.There are many ways that regulators aim to fight the opioid epidemic. For example, methadone clinics offer long-term treatment options for addicts while behavioral treatments are designed to help people kick their addiction. The problem is that these solutions don’t address the underlying problem of nearly one-third of Americans living with chronic pain—chronic pain that needs some form of treatment.The legalization of medical cannabis across a growing number of states could offer a solution. According to the American Medical Association, states with modernized cannabis laws see a significant reduction in opioid dependence and opioid-related deaths. The assumption is that many chronic pain sufferers are amenable to using cannabinoids as an alternative treatment, and cannabinoids don’t have the same adverse side-effects.Click here to receive an investor deck and corporate updatesBioTrackTHC Powers ResearchThe State of Illinois has become a pioneer in measuring these trends with its Opioid Alternative Pilot Program. By tracking patients taking alternative medications, such as medical cannabis, the state hopes to find clear pathways to fight the nationwide epidemic. The challenge is tracking the use of medical cannabis since it occurs outside of the traditional medical system where doctors issue prescriptions purchased at pharmacies.Helix TCS Inc.’s (OTCQB: HLIX) BioTrackTHC subsidiary provides the key missing ingredient—a software application that tracks medical cannabis across the supply chain. Earlier this month, the company announced that the State of Illinois selected its software to track medical cannabis sales for patients participating in the Opioid Alternative Pilot Program, in addition to its existing tracking and tracing of the state’s medical cannabis supply chain.“Helix TCS is uniquely positioned to deliver the critical tracking and compliance technology infrastructure surrounding both forms of medicine in existing and emerging medical and recreational cannabis markets through our subsidiary, BioTrackTHC, and will be able to leverage tracking data to directly correlate changes in opioid use to medical cannabis expansion,” says Helix TCS Executive Chairman and CEO, Zachary L. Venegas.The agreement in Illinois could become a template for other states looking to implement similar programs, with key states, including New York, considering this path and also utilizing the BioTrackTHC solution for government oversight of the state’s medical cannabis ...

Company Plans to Acquire Majority Interest in Cebadora ™ Brand Yerba Mate BeveragesDenver, CO - (NewMediaWire) - February 27, 2019 - The Pocket Shot Company, (OTC: PCKK), a ten-year-old specialty alcoholic beverage distribution company based in Denver, Colorado, is pleased to announce that it has entered into a Letter of Intent (LOI) to acquire a 51% interest for stock and cash consideration in Cebadora, Inc., an early stage California based company engaged in the development of yerba mate based beverages. The letter of intent also allows The Pocket Shot Company an option to further acquire up to an 81% interest in Cebadora, Inc. “We are excited to expand our existing beverage business with our development plans for yerba mate based products infused with cannabidiol (CBD) and cannabis, in accordance with what is specifically allowed in various markets,” said David Lamadrid, CEO of the Pure Harvest Cannabis Group and the Pocket Shot Company. “Cebadora presents an ideal opportunity to offer health conscious consumers alternative products that support wellness and active life styles.” “On behalf of Cebadora, we are thrilled to be working with the team at Pure Harvest. Their resources and knowledge, both in the beverage space and in cannabis infused product lines, makes them an ideal partner for us,” stated Lucas Hildebrand, CEO of Cebadora Inc. “Pure Harvest also provides Cebadora with strategic opportunities to expand our product lines and execute our vision on a much larger scale." The Cebadora™ brand is inspired by the very popular South American tea beverage called “yerba mate”, a mineral rich stimulant known for its anti-inflammatory and antioxidant properties. The naturally caffeinated beverage is widely known as the National Drink of both Argentina and Uruguay. By long standing tradition it is a “Cebador(a)” that prepares and serves a great tasting yerba mate and ceremoniously shares with a group of friends. About the Pure Harvest Cannabis GroupThe Pure Harvest Cannabis Group is a new science-based medical cannabis company with a commitment to the highest quality products, ethical growing standards, environmental awareness, and corporate integrity. Pure Harvest intends to develop into a large scale vertically integrated producer and distributor in large, established, and growing markets.Pure Harvest is focused on developing precision dosed cannabinoid health and wellness consumer products. The Company’s goals include establishing Pure Harvest Cannabis as an iconic consumer product brand offering a wide variety of cannabis/CBD products that can be sold in multiple international markets that have legalized cannabis and hemp-derived products.Pure Harvest has recently merged with The Pocket Shot Company and plans to transition into a vertically integrated multi-state operator (MSO) and multi-country producer and purveyor of the finest quality cannabis and hemp derived products for active life styles, and to support patient health and well-being.About The Pocket Shot CompanyThe Pocket Shot Company, a portable spirit company, designs, produces, and distributes hard liquor and other beverages in flexible single-serving pouches in the United States. It offers Pocket Shot, a grab and go package for alcoholic beverages. The Company offers Pocket Shot in bourbon, whiskey, rum, vodka, brandy, tequila, cherry vodka, cinnamon whiskey, peppermint schnapps, spiced rum, and cinnamon schnapps flavors. It also offers its products through online retailers. The Pocket Shot Company was founded in 2003 and is based in Evergreen, Colorado.Forward Looking StatementsCertain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking ...